A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy
Clinical trial NCT02177071 · COMPLETED
Trial details
- NCT number
- NCT02177071
- Sponsor
- Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-09
- Primary completion
- 2021-06-01
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.